Agranulocytosis associated with chronic oral administration of cloxacillin for suppression of staphylococcal osteomyelitis
- 1 April 1982
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 12 (2) , 203-206
- https://doi.org/10.1002/ajh.2830120213
Abstract
Oral cloxacillin was used for chronic suppression of a 59‐year‐old woman with staphylococcal osteomyelitis. She received 380.5 gm of cloxacillin over 263 consecutive days. Severe agranulocytosis followed, reverting rapidly to normal with cessation of drug. The absence of signs of an allergic reaction such as rash, fever, or eosinophilia suggests that cloxacillin, like other semisynthetic penicillins, may exert a direct bone marrow toxicity.Keywords
This publication has 12 references indexed in Scilit:
- Neutropenia Induced by Semisynthetic PenicillinSouthern Medical Journal, 1980
- NEUTROPENIA AFTER CONSECUTIVE TREATMENT COURSES WITH NAFCILLIN AND PIPERACILLINThe Lancet, 1979
- Agranulocytosis during Therapy with Orally Administered CloxacillinAmerican Journal of Clinical Pathology, 1978
- Nafcillin-Induced Neutropenia in ChildrenPediatrics, 1978
- Leukopenia and Granulocytopenia After Oxacillin TherapySouthern Medical Journal, 1977
- Nafcillin-induced agranulocytosisPublished by American Medical Association (AMA) ,1975
- Neutropenia probably resulting from nafcillinJAMA, 1975
- Bone marrow depression due to methicillin, a semisynthetic penicillinClinical Pharmacology & Therapeutics, 1964
- The Newer PenicillinsAnnals of Internal Medicine, 1962
- Bone-Marrow Depression Resulting from the Administration of MethicillinNew England Journal of Medicine, 1962